Report: FDA Strengthens NSAIDs Warnings
The US Food and Drug Administration (FDA) is strengthening an existing label warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. Based on the FDA’s review of new safety information, it is now requiring updates to the drug labels of all prescription NSAIDs.